To our knowledge, our research reveals for the first time that STING activation in DRG neuron drives bone cancer pain via the TBK1/IKK/NF-κB/proinflammatory factor signaling pathways, which could reverse by C-176 (Fig. 9). This evidence concerns the gene NFKB1 and bone neoplasm.